
Samuel A. Acquah
Examiner (ID: 20)
| Most Active Art Unit | 1711 |
| Art Unit(s) | 1207, 1754, 1503, 2899, 1711, 1774 |
| Total Applications | 2690 |
| Issued Applications | 2329 |
| Pending Applications | 91 |
| Abandoned Applications | 269 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 19/110409 | COMPOSITION AND METHOD FOR REMOVING PLAQUE FROM AN ARTERY | Mar 9, 2025 | Pending |
Array
(
[id] => 20059612
[patent_doc_number] => 20250197834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/071092
[patent_app_country] => US
[patent_app_date] => 2025-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 140575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19071092
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/071092 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | Mar 4, 2025 | Pending |
Array
(
[id] => 20059615
[patent_doc_number] => 20250197837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/069321
[patent_app_country] => US
[patent_app_date] => 2025-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19069321
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/069321 | SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF | Mar 3, 2025 | Pending |
Array
(
[id] => 20121816
[patent_doc_number] => 20250236847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 19/060404
[patent_app_country] => US
[patent_app_date] => 2025-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19060404
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/060404 | COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION | Feb 20, 2025 | Pending |
Array
(
[id] => 19877138
[patent_doc_number] => 20250109395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME
[patent_app_type] => utility
[patent_app_number] => 18/970552
[patent_app_country] => US
[patent_app_date] => 2024-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18970552
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/970552 | S. pyogenes CAS9 mutant genes and polypeptides encoded by same | Dec 4, 2024 | Issued |
Array
(
[id] => 20393473
[patent_doc_number] => 20250368948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-04
[patent_title] => PRODUCT, SYSTEM AND METHOD OF CELL CULTIVATION
[patent_app_type] => utility
[patent_app_number] => 18/927171
[patent_app_country] => US
[patent_app_date] => 2024-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 125322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927171
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/927171 | PRODUCT, SYSTEM AND METHOD OF CELL CULTIVATION | Oct 24, 2024 | Pending |
Array
(
[id] => 19855764
[patent_doc_number] => 12258588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/919946
[patent_app_country] => US
[patent_app_date] => 2024-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 9
[patent_no_of_words] => 13318
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/919946 | Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof | Oct 17, 2024 | Issued |
Array
(
[id] => 19877133
[patent_doc_number] => 20250109390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => COMPOSITIONS FOR PREVENTING OR TREATING CORONAVIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/914016
[patent_app_country] => US
[patent_app_date] => 2024-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18914016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/914016 | Compositions for preventing or treating coronavirus infections | Oct 10, 2024 | Issued |
Array
(
[id] => 19809737
[patent_doc_number] => 12241109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Host cells comprising a recombinant casein protein and a recombinant kinase protein
[patent_app_type] => utility
[patent_app_number] => 18/886925
[patent_app_country] => US
[patent_app_date] => 2024-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 43
[patent_no_of_words] => 90167
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886925
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/886925 | Host cells comprising a recombinant casein protein and a recombinant kinase protein | Sep 15, 2024 | Issued |
Array
(
[id] => 19682411
[patent_doc_number] => 20250000956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => RECOMBINANT CELL WALL HYDROLASES
[patent_app_type] => utility
[patent_app_number] => 18/882318
[patent_app_country] => US
[patent_app_date] => 2024-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882318
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/882318 | Recombinant cell wall hydrolases | Sep 10, 2024 | Issued |
Array
(
[id] => 20059650
[patent_doc_number] => 20250197872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => ALLULOSE EPIMERASE EXPRESSION CASSETTE AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/808665
[patent_app_country] => US
[patent_app_date] => 2024-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18808665
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/808665 | ALLULOSE EPIMERASE EXPRESSION CASSETTE AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME | Aug 18, 2024 | Pending |
Array
(
[id] => 19991125
[patent_doc_number] => 20250129347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/798042
[patent_app_country] => US
[patent_app_date] => 2024-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18798042
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/798042 | ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES | Aug 7, 2024 | Pending |
Array
(
[id] => 19800825
[patent_doc_number] => 20250066750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity
[patent_app_type] => utility
[patent_app_number] => 18/795872
[patent_app_country] => US
[patent_app_date] => 2024-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18795872
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/795872 | Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity | Aug 5, 2024 | Pending |
Array
(
[id] => 20048343
[patent_doc_number] => 20250186565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/777129
[patent_app_country] => US
[patent_app_date] => 2024-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777129
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/777129 | CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS | Jul 17, 2024 | Pending |
Array
(
[id] => 19631460
[patent_doc_number] => 20240409909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => ALPHA-AMYLASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/774233
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774233
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774233 | ALPHA-AMYLASE VARIANTS | Jul 15, 2024 | Pending |
Array
(
[id] => 20059649
[patent_doc_number] => 20250197871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => PROMOTER FOR CONSTITUTIVE EXPRESSION, TARGET PROTEIN EXPRESSION SYSTEM INCLUDING SAME, AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/772544
[patent_app_country] => US
[patent_app_date] => 2024-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18772544
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/772544 | PROMOTER FOR CONSTITUTIVE EXPRESSION, TARGET PROTEIN EXPRESSION SYSTEM INCLUDING SAME, AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME | Jul 14, 2024 | Pending |
Array
(
[id] => 19746032
[patent_doc_number] => 20250034597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci
[patent_app_type] => utility
[patent_app_number] => 18/764634
[patent_app_country] => US
[patent_app_date] => 2024-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18764634
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/764634 | RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci | Jul 4, 2024 | Pending |
Array
(
[id] => 19685445
[patent_doc_number] => 20250003990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 18/761632
[patent_app_country] => US
[patent_app_date] => 2024-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18761632
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/761632 | ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS | Jul 1, 2024 | Pending |
Array
(
[id] => 19658803
[patent_doc_number] => 20240425868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => ENGINEERED PLASMODIA AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/752946
[patent_app_country] => US
[patent_app_date] => 2024-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18752946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/752946 | ENGINEERED PLASMODIA AND RELATED METHODS | Jun 24, 2024 | Pending |
Array
(
[id] => 20007453
[patent_doc_number] => 20250145675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => PRODUCTION OF NATURAL PEPTIDE SWEETENER
[patent_app_type] => utility
[patent_app_number] => 18/745784
[patent_app_country] => US
[patent_app_date] => 2024-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745784
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/745784 | PRODUCTION OF NATURAL PEPTIDE SWEETENER | Jun 16, 2024 | Pending |